183 related articles for article (PubMed ID: 31446828)
1. NT-proBNP and Risk of Dementia in a General Japanese Elderly Population: The Hisayama Study.
Nagata T; Ohara T; Hata J; Sakata S; Furuta Y; Yoshida D; Honda T; Hirakawa Y; Ide T; Kanba S; Kitazono T; Tsutsui H; Ninomiya T
J Am Heart Assoc; 2019 Sep; 8(17):e011652. PubMed ID: 31446828
[TBL] [Abstract][Full Text] [Related]
2. Urinary N-terminal pro-B-type natriuretic peptide as a biomarker for cardiovascular events in a general Japanese population: the Hisayama Study.
Yamasaki K; Hata J; Ide T; Nagata T; Sakata S; Yoshida D; Honda T; Hirakawa Y; Nakano T; Kitazono T; Tsutsui H; Ninomiya T
Environ Health Prev Med; 2021 Apr; 26(1):47. PubMed ID: 33845756
[TBL] [Abstract][Full Text] [Related]
3. Change in NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Level and Risk of Dementia in Multi-Ethnic Study of Atherosclerosis (MESA).
Ostovaneh MR; Moazzami K; Yoneyama K; A Venkatesh B; Heckbert SR; Wu CO; Shea S; Post WS; Fitzpatrick AL; Burke GL; Bahrami H; Sanchez OA; Daniels LB; Michos ED; Bluemke DA; Lima JAC
Hypertension; 2020 Feb; 75(2):316-323. PubMed ID: 31865797
[TBL] [Abstract][Full Text] [Related]
4. Growth Differentiation Factor 15 and NT-proBNP as Blood-Based Markers of Vascular Brain Injury and Dementia.
McGrath ER; Himali JJ; Levy D; Conner SC; DeCarli C; Pase MP; Ninomiya T; Ohara T; Courchesne P; Satizabal CL; Vasan RS; Beiser AS; Seshadri S
J Am Heart Assoc; 2020 Oct; 9(19):e014659. PubMed ID: 32921207
[TBL] [Abstract][Full Text] [Related]
5. Serum N-terminal pro-B-type natriuretic peptide as a predictor for future development of atrial fibrillation in a general population: the Hisayama Study.
Nagata T; Hata J; Sakata S; Oishi E; Honda T; Furuta Y; Ohara T; Yoshida D; Hirakawa Y; Shibata M; Ide T; Kitazono T; Tsutsui H; Ninomiya T
Int J Cardiol; 2020 Dec; 320():90-96. PubMed ID: 32592745
[TBL] [Abstract][Full Text] [Related]
6. High-sensitivity cardiac troponin I and NT-proBNP as predictors of incident dementia and Alzheimer's disease: the FINRISK Study.
Tynkkynen J; Hernesniemi JA; Laatikainen T; Havulinna AS; Salo P; Blankenberg S; Zeller T; Salomaa V
J Neurol; 2017 Mar; 264(3):503-511. PubMed ID: 28039523
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Elderly Patients With Valvular Heart Disease.
Zhang B; Xu H; Zhang H; Liu Q; Ye Y; Hao J; Zhao Q; Qi X; Liu S; Zhang E; Xu Y; Gao R; Pibarot P; Clavel MA; Wu Y;
J Am Coll Cardiol; 2020 Apr; 75(14):1659-1672. PubMed ID: 32273031
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
Zhu Q; Xiao W; Bai Y; Ye P; Luo L; Gao P; Wu H; Bai J
Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
[TBL] [Abstract][Full Text] [Related]
10. The N-terminal pro B-type natriuretic peptide, and risk of dementia and cognitive decline: a 10-year follow-up study in the general population.
Mirza SS; de Bruijn RF; Koudstaal PJ; van den Meiracker AH; Franco OH; Hofman A; Tiemeier H; Ikram MA
J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):356-62. PubMed ID: 25918047
[TBL] [Abstract][Full Text] [Related]
11. N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in a Japanese community: the Hisayama study.
Doi Y; Ninomiya T; Hata J; Hirakawa Y; Mukai N; Ikeda F; Fukuhara M; Iwase M; Kiyohara Y
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2997-3003. PubMed ID: 21921261
[TBL] [Abstract][Full Text] [Related]
12. Serum N-terminal Pro-brain Natriuretic Peptide Level is Associated with the Development of Chronic Kidney Diseases in Patients with Type 2 Diabetes.
Sawada R; Hashimoto Y; Senmaru T; Tanaka M; Ushigome E; Yamazaki M; Fukui M
Endocr Metab Immune Disord Drug Targets; 2018; 18(6):590-595. PubMed ID: 29697035
[TBL] [Abstract][Full Text] [Related]
13. Increase in N-terminal pro-brain natriuretic peptide levels, renal function and cardiac disease in the oldest old.
Poortvliet R; de Craen A; Gussekloo J; de Ruijter W
Age Ageing; 2015 Sep; 44(5):841-7. PubMed ID: 26209786
[TBL] [Abstract][Full Text] [Related]
14. Moderate Levels of N-Terminal Pro-B-Type Natriuretic Peptide is Associated with Increased Risks of Total and Ischemic Strokes among Japanese: The Circulatory Risk in Communities Study.
Ebihara K; Yamagishi K; Umesawa M; Muraki I; Cui R; Imano H; Kubota Y; Hayama-Terada M; Shimizu Y; Ohira T; Sankai T; Okada T; Kitamura A; Kiyama M; Iso H;
J Atheroscler Thromb; 2020 Aug; 27(8):751-760. PubMed ID: 31932552
[TBL] [Abstract][Full Text] [Related]
15. Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing.
deFilippi CR; Christenson RH; Gottdiener JS; Kop WJ; Seliger SL
J Am Coll Cardiol; 2010 Feb; 55(5):441-50. PubMed ID: 20117457
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
[TBL] [Abstract][Full Text] [Related]
17. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.
Daniels LB; Laughlin GA; Clopton P; Maisel AS; Barrett-Connor E
J Am Coll Cardiol; 2008 Aug; 52(6):450-9. PubMed ID: 18672166
[TBL] [Abstract][Full Text] [Related]
18. Comparison of midregional pro-A-type natriuretic peptide and the N-terminal pro-B-type natriuretic peptide for predicting mortality and cardiovascular events.
van Hateren KJ; Alkhalaf A; Kleefstra N; Groenier KH; de Jong PE; de Zeeuw D; Gans RO; Struck J; Bilo HJ; Gansevoort RT; Bakker SJ
Clin Chem; 2012 Jan; 58(1):293-7. PubMed ID: 21948291
[TBL] [Abstract][Full Text] [Related]
19. The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure.
Fu S; Xie L; Li D; Ye P; Luo L
Clin Interv Aging; 2015; 10():359-65. PubMed ID: 25670892
[TBL] [Abstract][Full Text] [Related]
20. N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes.
Hamano K; Nakadaira I; Suzuki J; Gonai M
Vasc Health Risk Manag; 2014; 10():585-9. PubMed ID: 25328404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
